Voima Ventures — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Epigenica is a life sciences company working in multi-omics, biomarker discovery, and diagnostics.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSolna, SE
Simon Elsässer(Co-founder)inMohamad Takwa(Co-founder)
Co-investorsAlmi InvestLeksell Social VenturesNavigare Ventures
Alba is a marketplace that matches families in Latin America with childcare providers, drawing on caregivers already connected to a family's social network.
HealthtechMarketplaces
Dan SternJuan FantoniMaria Teresa Sante RossMauricio GiadachTesi Del Sante
Co-investors500 GlobalExceptional VenturesNoaberUnconventional Ventures
Farang is an AI research lab developing foundational large language models built on a custom architecture, with a focus on specialized on-device models for consumer and enterprise use.
AI & Machine LearningDeep TechEnterprise SoftwareSweden, SE
Emil Romanusin
Co-investorsAPEX Ventures
Gosta Labs builds healthcare-specialized AI models and an "AI operating system" that automates clinical note generation, structures patient data, and supports real-time clinical decision-making for healthcare professionals and public and private healthcare providers.
AI & Machine LearningDigital HealthHealthtech
Lauri Sippola(Co-founder)Henri Viertolahti(Co-founder)
Hormona provides digital health resources and education for women's hormonal health management across all life stages.
Digital HealthFemTechHealthtechWellness & FitnessWeybridge, GB
Karolina Löfqvist(Founder)in
Co-investorsSupernode GlobalTechstarsSFC CapitalStartup Funding Club
LIFTT is a network organization in Italy that connects investors and innovators to support the development of future-oriented competencies and entrepreneurship within the country.
Deep TechImpact & Social GoodNew MaterialsSector AgnosticSemiconductorsTurku, IT
Stefano Buono(President)
Co-investorsElysia CapitalAlumni VenturesIAG Capital PartnersJ-VenturesSerpentine Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


















